Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Diabetes Treatment and Management, Diabetes Management and Research, Pancreatic function and diabetes, and Metabolism, Diabetes, and Cancer.
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes
Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials
Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent
Semaglutide improves health‐related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk ( <scp>SUSTAIN</scp> 6)
Cover Image, Volume 22, Issue 3
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Recovery of gut microbiota of healthy adults following antibiotic exposure
Glucagon-like peptide 1 in health and disease
Semaglutid ermöglichte eine anhaltende Abnahme des Körpergewichts bei Patienten mit Typ 2 Diabetes über 2 Jahre
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
Supportive and non-supportive interactions in families with a type 2 diabetes patient: an integrative review
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy
Ideglira Versus other Intensification Strategies In Patients With Type 2 Diabetes Inadequately Controlled on Basal Insulin – An Indirect Statistical Comparison
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials